default author photo

Karine Lacombe

Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP

France

Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department

Paris

France

SCHOLARLY PAPERS

9

DOWNLOADS

927

TOTAL CITATIONS

1

Scholarly Papers (9)

1.

Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial

Number of pages: 34 Posted: 03 Aug 2022
University of Oslo - Section for Clinical Immunology and Infectious Diseases, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, University of Oslo - Institute of Clinical Medicine, University of Lille, affiliation not provided to SSRN, University of Verona, Hospital Universitario Virgen Macarena - Unidad Clínica de Enfermedades Infecciosas, affiliation not provided to SSRN, Université Libre de Bruxelles (ULB), Medical University of Innsbruck, Government of Portugal - Unidade Local de Saúde de São João, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, Sorbonne University, University of Oslo - Division of Emergencies and Critical Care, University of Claude Bernard Lyon 1, affiliation not provided to SSRN, University of Pécs, National and Kapodistrian University of Athens, University Hospital Brno, University of Basel - University Hospital Basel, Hacettepe University, Technische Universität München (TUM), Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Oslo - Oslo University Hospital, Sorbonne University, University of Oslo - Oslo University Hospital, affiliation not provided to SSRN, Vestre Viken Hospital Trust, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, University of Oslo - Institute of Clinical Medicine, University of Stavanger - Stavanger University Hospital, Hospital Universitario La Paz, Vestre Viken Hospital Trust, University Hospital North Norway, Hospices Civils de Lyon - Service de Médecine Intensive-Réanimation, Akershus University Hospital - Department of Infectious Diseases, Norwegian Institute of Public Health, Sorbonne University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Oslo - Department of Immunology and Transfusion Medicine, Hospices Civils de Lyon - Laboratoire de Virologie, University of Nantes - INSERM, University of Oslo - Oslo University Hospital, Norwegian Institute of Public Health, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, affiliation not provided to SSRN, University of Oslo - Department of Research Support for Clinical Trials and Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP
Downloads 176 (428,796)

Abstract:

Loading...

COVID-19, immunomodulator, safety, baricitinib, JAK inhibitor

2.

Effects of Jak Inhibitors in Adults Hospitalized Due to Covid-19: A Systematic Review and Individual Participant Data Meta-Analysis of Randomized Clinical Trials

Number of pages: 27 Posted: 03 Oct 2024
Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, University of Basel, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University Hospitals of Geneva, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), The Emmes Company, Hospital Universitario de Fuenlabrada, Hospital Universitario de Fuenlabrada, Ospedali Riuniti di Ancona, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Mazandaran University of Medical Sciences, University of Cambridge, NHS Foundation Trust - Cambridge University Hospitals, Hospital Universitario La Paz, Hospital Universitario La Paz, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Hospital Israelita Albert Einstein, Hospital Israelita Albert Einstein, University of Sydney - George Institute for Global Health, Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, Norwegian Institute of Public Health, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Université Libre de Bruxelles (ULB) - Department of Infectious Disease, Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, Hôpital Bichat, APHP, Université Paris Cité, Université Paris Cité, Université Paris Cité, University of Nantes - INSERM, Sorbonne University, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Section for Clinical Immunology and Infectious Diseases and University of Basel - University Hospital Basel
Downloads 175 (437,795)

Abstract:

Loading...

3.

Immunogenicity and Reactogenicity of Heterologous and Homologous mRNA-1273 and BNT162b2 Vaccination: A Multicenter Non-Inferiority Randomized Trial

Number of pages: 22 Posted: 20 Dec 2021
Centre Hospitalier Pierre Bénite - Infectious Diseases Unit, Assistance Publique-Hôpitaux de Paris - Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Aix Marseille Université - Emerging Viruses Unit, Assistance Publique-Hôpitaux de Paris - Clinical Investigation Center (CIC 1417), University of Caen Normandie - Infectious and Tropical Diseases Department, University Grenoble Alpes - Infectious Diseases Department, University Hospital Center of Tours - Department of General Pediatrics, University of Claude Bernard Lyon 1 - Department of infectious and tropical diseases, Université de Rennes 1 - Inserm, CIC 1414 (Centre d’investigation clinique de Rennes, Service de Pharmacologie Clinique), Perpignan Hospital Center - Infectious and Tropical Disease Unit (SMIT Perpignan), University of Lille - Department of Infectious Diseases, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Strasbourg - Centre d'Investigation Clinique (CIC) INSERM 1434, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Hospital Center Bretagne Atlantique - House of Preventive Medicine, Centre Hospitalier Alpes Léman - Internal Medicine Department, University of Montpellier - Virulence bactérienne et infections chroniques (VBIC), University of Caen Normandie - Infectious and Tropical Diseases Department, University Grenoble Alpes - Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris - Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Assistance Publique-Hôpitaux de Paris - Clinical Investigation Center (CIC 1417), Assistance Publique-Hôpitaux de Paris - Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Assistance Publique-Hôpitaux de Paris - Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Assistance Publique-Hôpitaux de Paris - Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Aix Marseille Université - Emerging Viruses Unit, Assistance Publique-Hôpitaux de Paris - Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (Unité de Recherche Clinique (URCEST), Assistance Publique-Hôpitaux de Paris - Clinical Investigation Center (CIC 1417) and affiliation not provided to SSRN
Downloads 132 (551,165)

Abstract:

Loading...

SARS-CoV-2, COVID-19 vaccine, Immunological efficacy, Randomized trial, Heterologous vaccination, mRNA vaccine, BNT162b2 vaccine, mRNA-1273 vaccine.

4.

Avdoralimab (anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FORCE)

Number of pages: 26 Posted: 07 Feb 2022
La Timone University Hospital - AP-HM, affiliation not provided to SSRN, Université Côte d'Azur - Clinical Research Unit Côte d’Azur, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Innate Pharma - Innate Pharma Research Laboratories, affiliation not provided to SSRN, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, affiliation not provided to SSRN, affiliation not provided to SSRN, Université Cote d'Azur - Nice University Hospital, Aix-Marseille University - Assistance Publique - Hôpitaux de Marseille (AP-HM), Aix-Marseille University - Centre d'Immunologie de Marseille-Luminy and affiliation not provided to SSRN
Downloads 107 (659,652)

Abstract:

Loading...

5.

Strengthening the Patient Pathway for a Better Hepatitis C Care Cascade in the Most Vulnerable Populations: The French PARCOURS Cohort

Number of pages: 28 Posted: 11 Jul 2022
Bichat-Claude Bernard Hospital - Department of Infectious and Tropical Diseases, Hôpital Avicenne (APHP) - Unité d’hépatologie, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, APHP Hospital Cochin - Unité d'Hépatologie, Établissement Public de Santé National de Fresnes, Association Gaïa Paris, University Hospital of Henri-Mondor, APHP - Service d’hépatologie, University Hospital of Henri-Mondor, APHP - Department of Clinical Immunology and Infectious Disease and Independent
Downloads 93 (736,406)

Abstract:

Loading...

Viral hepatitis C elimination, Direct-acting antivirals, Cascade of care, Detainees, Intravenous drug users, Migrants

6.

Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent Plasma

Number of pages: 36 Posted: 20 May 2022
Aix-Marseille University - Etablissement Français du Sang (EFS), INSERM U1059 SAINBIOSE, National Center of Scientific Research, National Center of Scientific Research, Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), INSERM U1059 SAINBIOSE, Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), University of Paris - Laboratory of Human Genetics of Infectious Diseases, University of Paris - Laboratory of Human Genetics of Infectious Diseases, Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), University of Paris - Laboratory of Human Genetics of Infectious Diseases, National Center of Scientific Research, Aix-Marseille University - Etablissement Français du Sang (EFS), Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, University of Paris - Laboratory of Human Genetics of Infectious Diseases and Aix-Marseille University - Etablissement Français du Sang (EFS)
Downloads 73 (860,052)

Abstract:

Loading...

transfusion, Endothelial Cells, Convalescent Plasma, COVID-19, Inflammation, Adverse Events

7.

Convalescent Plasma Improves Overall Survival in Patients with B-Cell Lymphoid Malignancies and COVID-19:  A Longitudinal Cohort and Propensity Score Analysis

Number of pages: 37 Posted: 03 Nov 2021
University of Paris-Saclay - Department of Hematology, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Sorbonne University - INSERM, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Hôpital André Mignot - Department of Hematology, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Hôpital André Mignot - Department of Hematology, Assistance Publique-Hôpitaux de Paris - Department of Hematology, CHU de Montpellier - Department of Hematology, University of Paris - Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, University of Saint Etienne - Department of Hygiene and Infectious Diseases, Hospices Civils de Lyon - Pneumology Department, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP and affiliation not provided to SSRN
Downloads 61 (961,006)
Citation 1

Abstract:

Loading...

Convalescent plasma, COVID-19, Hematological malignancies, Anti-CD20, B-cell deficiency

8.

Higher Mortality in People Living with HIV after Cure of Hepatitis C by Direct-Acting Antivirals Compared to Those Without Hepatitis C: Results from the ANRS CO4 FHDH Cohort

Number of pages: 24 Posted: 22 Aug 2022
Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Sorbonne University - Department of Infectious Diseases, University of Nantes - Infectious Diseases Department, affiliation not provided to SSRN, Croix Rousse Hospital - Hepatology Unit, Dijon University Hospital - Clinical Epidemiology Unit, Université de Rennes 1 - Department of Infectious Diseases and Intensive Care Medicine, Université Paris Cité - Department of Immunology and Infectious Diseases, University of Paris - Saint Louis Hospital, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP and Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP
Downloads 55 (1,010,164)

Abstract:

Loading...

HIV/HCV coinfection, DAA treatment, SVR, mortality

9.

Hepatitis C and NAFLD as Main Causes of Liver-Related Morbidity and Mortality in the French General Population: A Nationwide Study (NASH-CO Study)

Number of pages: 22 Posted: 13 Jul 2022
Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Anger University Hospital - HepatoGastroenterology Department, University of Bordeaux - Centre d'Investigation de la Fibrose Hépatique, University of Dijon - Department of Endocrinology-Diabetology, Université de Versailles Saint-Quentin, Université de Versailles Saint-Quentin, Université de Versailles Saint-Quentin, University of Strasbourg - Hôpital de Hautepierre and Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP
Downloads 55 (1,031,043)

Abstract:

Loading...

NAFLD, advanced fibrosis, Fatty Liver Index, Forns Index, cardiovascular diseases, chronic kidney disease, extrahepatic malignancies, mortality